Clinical Trial Update: CART-BCMA Cells for Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial of CART-BCMA CAR-T cells for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CART-BCMA CAR-T cells (BCMA-targeted CAR-T therapy)

Snippet

Sponsor: University of Pennsylvania | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED